Improved cost-effectiveness of short-course radiotherapy in elderly and/or frail patients with glioblastoma

Short-course radiotherapy (25 Gy in five fractions) was recently shown in a randomized phase III trial to be non-inferior to 40 Gy in 15 fractions in elderly and/or frail patients with glioblastoma multiforme. This study compared the cost-effectiveness of the two regimens.

http://ift.tt/2F06V6s